Leerink Partners Initiates Coverage On Entera Bio with Outperform Rating, Announces Price Target of $9
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Leerink Partners analyst David Risinger initiates coverage on Entera Bio (NASDAQ:ENTX) with a Outperform rating and announces Price Target of $9.
Leerink Partners analyst David Risinger initiates coverage on Entera Bio (NASDAQ:ENTX) with a Outperform rating and announces Price Target of $9.